Tuesday, April 28, 2015

At AACR, patients' odds are shifting

Monday, April 20, 2015, 1:33 PM
If you see a bunch of very smart people wandering around Center City this week, it’s the 19,000 or so attendees at the American Association for Cancer Research (AACR) Annual Meeting. These conferences happen every few months and are a chance for researchers to present ongoing studies to peers... Read more

A ‘cancervention’ for young adults facing cancer

Tuesday, April 14, 2015, 2:57 PM
What do you do if you are a cancer patient in your twenties and can’t seem to find others like yourself? If you are Dakota Fisher-Vance and Cara Scharf, you start a cancer connection group that sponsors meet-ups for fellow survivors. This Saturday, those meet-ups will go to the next level with... Read more

'The alphabet soup' of cancer treatments

Friday, April 3, 2015, 3:33 PM
It took a while, but there are some scientific insights I gained at the Melanoma Research Alliance’s Scientific Retreat a month ago and the American Association of Cancer Research’s Tumor Immunology and Immunotherapy Conference in December. Most things I still don’t understand so... Read more

Jackie King: The lost voice of melanoma

Thursday, March 26, 2015, 9:52 AM
Being so involved in the melanoma world, I meet fellow cancer patients on a too-frequent basis. More and more, these patients are not of geriatric age, but my age or younger. One such patient, Jackie King, was diagnosed in 2012 with melanoma at age 19. She and I met while doing a video spot at... Read more

Where to find help after a diagnosis

Tuesday, March 24, 2015, 12:05 PM
A friend and I had a conversation two months ago about where to turn if he were to get cancer. His answer? “I’d email you first, and then start Googling.” For those 1,658,370 people unlucky enough to get diagnosed with cancer this year, where will they go after stumbling out... Read more

Top 10 melanoma buzzwords from the Melanoma Research Alliance’s Scientific Retreat

Friday, March 13, 2015, 2:19 PM
1. Momentum Melanoma is leading the way on the crest of the immunotherapy treatments. I couldn’t get an active number of melanoma clinical trials involving immunotherapies, but it’s in the double digits (unfortunately, many – like mine – are already closed to new participants)... Read more

A surprise party for more than one Sharpe

Tuesday, March 10, 2015, 4:10 PM
I planned a birthday party for my five year old – and no one showed up. We had family coming in – my parents, Jen’s brother, my brother, and their families – for Josie’s Saturday afternoon birthday party in the park. She had requested a “hula party” for her... Read more

Patient #1's journey comes full circle at MRA Conference

Monday, March 2, 2015, 12:07 PM
For the second year in a row, I was invited to attend the Melanoma Research Alliance’s Scientific Research Conference, and for the second year in a row, I tried to wade through the combination of biology, chemistry, and statistics to understand what is happening in the research world. For the... Read more

Streamlining clinical trials at SCOPE

Wednesday, February 25, 2015, 1:16 PM
Clinical trials have LOTS of rules. Between the pharmaceutical companies, research sites (like Moffitt or UPenn), other associated stakeholders, and governing organizations, the start-up process for a trial can be painfully slow. Add in the enormous amount of legalese that comes with using humans... Read more

Proactively managing your diagnosis

Friday, February 20, 2015, 4:44 PM
Want any more evidence that you need to take your health in your own hands? How about following the example of one man who diagnosed his wife’s tumor – by printing a 3D model of her head, tumor included. It’s a story that needs to be read multiple times to understand the complexity... Read more
About this blog
T.J. Sharpe is sharing his fight against Stage 4 Melanoma. A South Jersey native and Bishop Eustace graduate, he currently lives in Fort Lauderdale, FL with his wife Jennifer and children Josie and Tommy. He was Patient #1 in a clinical trial at Moffitt Cancer Center in Tampa as the first person worldwide to use this sequence of treatments to fight melanoma, and is currently in a second clinical trial at Holy Cross Hospital in Fort Lauderdale receiving Merck’s anti-PD-1 drug Lambrolizumab

The Patient #1 blog will update the progress of T.J.'s fight against cancer, and also touch on many cancer-related topics.

Follow T.J. on Twitter and Facebook. Reach T.J. at Patient1@tjsharpe.com.

T.J. Sharpe
Latest Health Videos
Also on Philly.com:
Stay Connected